Opinion|Videos|October 16, 2024
Comorbidities and Complications Associated With Friedreich Ataxia
Author(s)Sub Subramony, M.D.
Key Takeaways
- Cardiac complications like arrhythmias, heart failure, and myocardial infarction significantly impact mortality rates in patients with comorbidities.
- The interaction between cardiac issues and comorbidities such as diabetes and hypertension complicates patient management.
Sub Subramony, M.D., discusses the most prevalent complications and comorbidities in Friedreich ataxia, emphasizing the frequent cardiac complications and their significant impact on mortality rates.
Advertisement
Episodes in this series
Video content above is prompted by the following:
What are the most prevalent complications and comorbidities, and specifically, what cardiac complications are frequently encountered and how do they factor into mortality rates?
Advertisement
Related to this article
Full INTerpath-001 results show the individualized mRNA therapy plus pembrolizumab reduced recurrence risk in resected stage IIB-IV melanoma.
Kidney Week 2026 abstracts show that AMKD progresses quickly in routine practice, with or without diabetes, despite background CKD therapy.
Insurance barriers were the top reason 4 in 10 people prescribed long-acting PrEP at a Missouri clinic never received it, an IDWeek 2026 poster found.
A retrospective study suggests strength exercise may be a safer option than endurance exercise for some people with ACM.
Infant flu protection from maternal vaccination varied by timing, while pediatric vaccination fell to 49.4%, experts report at IDWeek 2026.
The NCCN’s latest esophageal/EGJ guidance raises durvalumab plus FLOT to a category 2A recommendation for PD-L1–negative, diffuse-type disease.
Legal and clinical experts examined the US medical aid in dying framework, its limits, and ethical debates.
The pilot pairs grocery stipends and community health worker support with members who have unmanaged diabetes and unmet social needs.
Advertisement
Advertisement
Trending on AJMC
1
Bepirovirsen Approval Offers New Option for Chronic HBV Treatment
2
Inhaled Amikacin Raises Culture Conversion in New MAC Lung Disease
3
Bronchiectasis GWAS Highlights Candidate Targets Shared With COPD
4
Uninsured Rate Rises to 11.2% as Coverage Erodes Before Medicaid Cuts
5